Follow
Nienke M. de Wit
Nienke M. de Wit
AmsterdamUmc, department of molecular cell biology and immunology
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
The blood brain barrier in Alzheimer’s disease
A Chakraborty, NM De Wit, WM Van Der Flier, HE De Vries
Vascular pharmacology 89, 12-18, 2017
1132017
Astrocytic ceramide as possible indicator of neuroinflammation
NM De Wit, S Den Hoedt, P Martinez-Martinez, AJ Rozemuller, MT Mulder, ...
Journal of neuroinflammation 16, 1-11, 2019
682019
Sphingolipids in Alzheimer's disease, how can we target them?
SM Crivelli, C Giovagnoni, L Visseren, AL Scheithauer, N de Wit, ...
Advanced drug delivery reviews 159, 214-231, 2020
652020
Liver X receptor alpha is important in maintaining blood-brain barrier function
E Wouters, NM De Wit, J Vanmol, SMA Van der Pol, B van Het Hof, ...
Frontiers in immunology 10, 1811, 2019
362019
Altered sphingolipid balance in capillary cerebral amyloid angiopathy
NM De Wit, H Snkhchyan, S Den Hoedt, D Wattimena, R De Vos, ...
Journal of Alzheimer's Disease 60 (3), 795-807, 2017
352017
The role of sphingolipids and specialized pro-resolving mediators in Alzheimer’s disease
NM De Wit, K Mol, S Rodríguez-Lorenzo, HE De Vries, G Kooij
Frontiers in immunology 11, 620348, 2021
292021
Inflammation at the blood-brain barrier: The role of liver X receptors
NM de Wit, J Vanmol, A Kamermans, JJA Hendriks, HE de Vries
Neurobiology of disease 107, 57-65, 2017
262017
Crossing borders in Alzheimer’s disease: AT cell’s perspective
L Van Olst, L Coenen, JM Nieuwland, C Rodriguez-Mogeda, NM De Wit, ...
Advanced drug delivery reviews 188, 114398, 2022
142022
Profiling the unique protective properties of intracranial arterial endothelial cells
DMA Hermkens, OCG Stam, NM de Wit, RD Fontijn, A Jongejan, ...
Acta neuropathologica communications 7, 1-16, 2019
122019
In vitro and ex vivo model systems to measure abc transporter activity at the blood-brain barrier
N M de Wit, G Kooij, H E de Vries
Current pharmaceutical design 22 (38), 5768-5773, 2016
102016
The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
M Kurtyka, F Wessely, S Bau, E Ifie, L He, NM de Wit, ABV Pedersen, ...
European Journal of Cell Biology 103 (2), 151406, 2024
12024
Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier
MR Holst, NM de Wit, B Ozgür, A Brachner, K Hyldig, A Appelt-Menzel, ...
Fluids and Barriers of the CNS 20 (1), 82, 2023
12023
Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2
D Vacondio, H Nogueira-Pinto, L Coenen, I Mulder, R Fontijn, ...
12023
Linking the sphingolipid profile and neuroinflammation in Alzheimer's disease
NM de Wit
2020
The system can't perform the operation now. Try again later.
Articles 1–14